Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: Revisiting the Evidence

Affiliations

Editorial

H Ballentine Carter. JAMA. 2018.

. 2018 May 8;319(18):1866-1868.

doi: 10.1001/jama.2018.4914.

¹ Department of Urology and the James Buchanan Brady Urologic Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.

No abstract available

Comment on

Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
US Preventive Services Task Force; Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW, Doubeni CA, Ebell M, Epling JW Jr, Kemper AR, Krist AH, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Siu AL, Tseng CW. US Preventive Services Task Force, et al. JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710. JAMA. 2018. PMID: 29801017
Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J. Fenton JJ, et al. JAMA. 2018 May 8;319(18):1914-1931. doi: 10.1001/jama.2018.3712. JAMA. 2018. PMID: 29801018